-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6

Benzinga·09/17/2026 09:52:48
Listen to the news
Roth Capital analyst Boobalan Pachaiyappan initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $6.